Patrick Girondi

Founder

Therapeutic Areas

Drug	Indication	Phase
Gene Therapy for Hemoglobinopathies (historically referred to as Thalagen)	Sickle Cell Disease and Beta Thalassemia	Pre-clinical / Early Clinical